Drugs / FP
last change Apr 2011 re-read 2 minutes ago

FP

Developed for
atopic eczema
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01299610 Dec 2010 → Mar 2011 atopic eczema GlaxoSmithKline Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FP ClinicalTrials.gov intervention name — accepted as the source's own label NCT01299610
Route Topical “FP 0.05% cream (as a positive control)” NCT01299610